Evidence map›Paper›PMID 38683487›Full record

ArticleMolecular diversity2024

A comparative analysis of computational drug repurposing approaches: proposing a novel tensor-matrix-tensor factorization method.

Arash Zabihian, Javad Asghari, Mohsen Hooshmand, Sajjad Gharaghani

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arash Zabihian *Department of Bioinformatics, Kish International Campus, University of Tehran, Kish, Iran.
Javad Asghari *Department of Computer Science and Information Technology, Institute of Advanced Studies in Basic Sciences, Zanjan, Iran.
Mohsen HooshmandDepartment of Computer Science and Information Technology, Institute of Advanced Studies in Basic Sciences, Zanjan, Iran. mohsen.hooshmand@iasbs.ac.ir.
Sajjad GharaghaniLaboratory of Bioinformatics and Drug Design, University of Tehran, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efficient drug discovery relies on drug repurposing, an important and open research field. This work presents a novel factorization method and a practical comparison of different approaches for drug repurposing. First, we propose a novel tensor-matrix-tensor (TMT) formulation as a new data array method with a gradient-based factorization procedure. Additionally, this paper examines and contrasts four computational drug repurposing approaches-factorization-based methods, machine learning methods, deep learning methods, and graph neural networks-to fulfill the second purpose. We test the strategies on two datasets and assess each approach's performance, drawbacks, problems, and benefits based on results. The results demonstrate that deep learning techniques work better than other strategies and that their results might be more reliable. Ultimately, graph neural methods need to be in an inductive manner to have a reliable prediction.

Indexed as

Drug RepositioningAlgorithmsComputational BiologyDeep LearningDrug DiscoveryHumansMachine LearningNeural Networks, ComputerDeep learningDrug repurposingGraph attention network (GAT)Machine learningPractical surveyTensor-matrix-tensor formulation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.